| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.25 | 9e-07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |